Proceedings of the 2020 Epilepsy Foundation Pipeline Conference: Emerging Drugs and Devices

被引：1
|
作者：
Boada, Christina M. [1 ]
Grossman, Scott N. [2 ]
Grzeskowiak, Caitlin L. [3 ]
Dumanis, Sonya [3 ]
French, Jacqueline A. [2 ]
机构：
[1] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[2] New York Univ Langone Hlth, Dept Neurol, New York, NY USA
[3] Epilepsy Fdn, Landover, MD USA
来源：
EPILEPSY & BEHAVIOR | 2021年 / 125卷
关键词：
Epilepsy; Seizure; Therapies; Devices; Diagnostics; Therapeutics; METABOTROPIC GLUTAMATE-RECEPTOR; ADJUNCTIVE CENOBAMATE; ALLOSTERIC MODULATOR; DOUBLE-BLIND; LONG-TERM; SEIZURES; EFFICACY; ANTICONVULSANT; CANNABIDIOL; SYSTEM;
D O I：
10.1016/j.yebeh.2021.108364
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
From August 27-28, 2020 the Epilepsy Foundation hosted the Pipeline Conference, exploring emerging issues related to antiepileptic drug and device development. The conference featured epilepsy therapeutic companies and academic laboratories developing drugs for focal epilepsies, innovations for rare and ultra-rare diseases, and devices both in clinical trials and approved for use. In this paper, we outline the virtual presentations by the authors, including novel data from their development pipeline. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数：15
相关论文
共 26 条
  • [1] The Epilepsy Foundation's 4th Biennial Epilepsy Pipeline Update Conference
    French, Jacqueline A.
    Schachter, Steven C.
    Sirven, Joseph
    Porter, Roger
    EPILEPSY & BEHAVIOR, 2015, 46 : 34 - 50
  • [2] Emerging drugs for focal epilepsy
    Mula, Marco
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (03) : 243 - 249
  • [3] Emerging drugs for epilepsy
    Kwan, Patrick
    Brodie, Martin J.
    EXPERT OPINION ON EMERGING DRUGS, 2007, 12 (03) : 407 - 422
  • [4] Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop
    Huizenga, Megan N.
    Fureman, Brandy E.
    Soltesz, Ivan
    Stella, Nephi
    EPILEPSY & BEHAVIOR, 2018, 85 : 237 - 242
  • [5] Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
    Bialer, Meir
    Johannessen, Svein I.
    Koepp, Matthias J.
    Levy, Rene H.
    Perucca, Emilio
    Tomson, Torbjorn
    White, H. Steve
    EPILEPSIA, 2018, 59 (10) : 1811 - 1841
  • [6] Challenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and Diagnostics Development conference
    Terman, Samuel W.
    Kirkpatrick, Laura
    Kerr, Wesley T.
    Akiyama, Lisa F.
    Baajour, Wadih
    Atilgan, Deniz
    Dorotan, Maria Kristina C.
    Choi, Hyoung Won
    French, Jacqueline A.
    EPILEPSIA, 2024, 65 (04) : 846 - 860
  • [7] Emerging drugs for focal epilepsy
    Mula, Marco
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (01) : 87 - 95
  • [8] Emerging pipeline drugs for hepatitis B infection
    Cox, Natravis
    Tillmann, Hans
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 713 - 729
  • [9] Emerging drugs for partial-onset epilepsy: a review of brivaracetam
    Gao, Lan
    Li, Shuchuen
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 719 - 734
  • [10] Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
    Bialer, Meir
    Johannessen, Svein I.
    Koepp, Matthias J.
    Levy, Rene H.
    Perucca, Emilio
    Tomson, Torbjorn
    White, H. Steve
    EPILEPSIA, 2018, 59 (10) : 1842 - 1866
123